// App-Quantinova.ai

TCT-408 : Thirty-day Outcome Following Polymeric Bioresorbable Scaffold Implantation in 347 STEMI Patients Enrolled in the Multicenter Registro Absorb Italiano (RAI Registry)

Researchers

Presenter

  • Alfonso Ielasi

Principal Investigators

  • Elisabetta Moscarella

  • Bruno Loi

  • Bernardo Cortese

  • Paolo Calabr-

  • Giuseppe Tarantini

  • Roberto Gistri

  • Francesco Pisano

  • Pietro Mazzarotto

  • Gabriele Gabrielli

  • Giampaolo Pasquetto

Medical Centers

  • Interventional Cardiology, Ospedale Maggiore, Lodi, Italy

  • USD Emodinamica, A.S.O. S. Croce e Carle, Cuneo, Italy

  • Interventional Cardiology, SS. Filippo e Nicola Hospital, Avezzano, Italy

  • Second University of Naples, Naples, Italy

  • Fatebenefratelli Hospital, Milano, Milan, Italy

  • ASST Bergamo Est, Ospedale Bolognini, Seriate, Italy

  • AORN Dei Colli Monaldi, Naples, Naples, Italy

  • Ospedale San Paolo, Savona, Italy

  • Cardiology Department Sacco University Hospital, Milan, Italy

  • AZIENDA OSPEDALIERA UNIVERSITARIA SENESE SIENA, Siena, Siena, Italy

  • Azienda Ospedaliera Brotzu, Cagliari, Italy

  • Padua South Hospital, MONSELICE, Padua, Italy

  • Mario Negri Research Institute, Milan, Italy

  • Cardinal Massaja Hospital, Asti, Italy

  • PADUA HOSPITAL, PADUA, Italy

  • Cardiologia, Fondazione IRCCS Policlinico San Matteo, Pavia, Pavia, Italy

  • Cardiology Division, A.O. Bolognini, Seriate, Italy

  • Interventional Cardiology, Parini Regional Hospital, Aosta, Italy

  • Haemodynamics - Azienda Ospedali Riuniti Ancona - Italy, Ancona, Ancona, Italy

  • Division of Cardiology, Mazzoni Hospital, Ascoli Piceno, Italy

  • spezzino, la spezia, La Spezia, Italy

  • Cardiology Division, Valduce Hospital, Como, Italy

  • Interventional Cardiology, A.O. Monaldi, Naples, Italy

Locations

  • Italy

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

Disease

  • Myocardial infarction

  • Angina

  • Venous thrombosis

Biomarkers

  • N/A

Drug/Treatment

  • Everolimus

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim